Failure of ditiocarb (diethyldithiocarbamate) therapy: was diet the reason?


It was the exciting message for HIV patients that inexpensive drug ditiocarb (diethyldithiocarbamate) was able to suppress the disease progression in clinical trials published 20 years ago in Lancet [1, 2]. Moreover, subsequent study (available in JAMA) confirmed ditiocarb as a potent drug against opportunistic infections in patients with symptomatic HIV… (More)